Pre-menstrual syndrome: A new concept in its pathogenesis and treatment

Medical Hypotheses

Volumn 62, Issue 1, 2004, Pages 130-132

  Levin, A M ^a  

^a NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROGESTERONE; STEROID;

ARTICLE; DRUG EFFECT; ESTROGEN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HYPOTHESIS; LUTEAL PHASE; PATHOGENESIS; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STEROID THERAPY; SYMPTOMATOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 1042300342     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00239-1     Document Type: Article

References (5)

1. Harper HA, et al. Review of physiological chemistry. 17th ed. Los Altos (CA): Lange Medical Publications; 1979. p. 94022.
2. Moncada S, et al. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43(2):109-42.
3. Peoine Carl J, et al. Vascular health as a therapeutic target in cardiovascular disease. University of Florida, USA, 1998.
4. McCrohon Jane A et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol 1996;45:435-41.
5. Levin AM. Personal observations, 2000.